Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study

NCT03629886 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT03629886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03629886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
August 22, 2018
Completion date
February 28, 2020
Enrollment
6,051 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia